Nanostics and OncoHelix Partner to Provide ClarityDX Prostate for Men at Risk of Having Aggressive Prostate Cancer in the Middle East Health and Family Nanostics and OncoHelix Partner to Provide ClarityDX Prostate for Men at Risk of Having Aggressive Prostate Cancer in the Middle East AETOS Wire 27 September، 2024 EDMONTON, Alberta & CALGARY, Alberta Nanostics Inc., a precision health company developing diagnostic tests with its ClarityDX®... Read More Read more about Nanostics and OncoHelix Partner to Provide ClarityDX Prostate for Men at Risk of Having Aggressive Prostate Cancer in the Middle East
